Assessment of major gaps

Dec 19, 2019

Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals.

Due to the increasing incidence and prevalence of neuroendocrine tumors (NETs), there is a need to assess any gaps in awareness and care. A survey was undertaken in 2017 to identify perceived unmet needs from the perspectives of patients/families, patient advocates and health care professionals (HCPs). The survey consisted of 33–37 questions (depending on type of respondent) across four areas: information, care, treatments and research.

Recent News

Corporate Sponsors – LILA International Logistics Ltd

Corporate Sponsors – LILA International Logistics Ltd

🏆Thank you so much to LILA International Logistics Ltd, who became one of Neuroendocrine Cancer UK's 'Corporate Champions' and kindly sponsored the production of our newly branded fundraising t-shirts. LILA reached out to us and wanted to show their support, after the...

read more
Neuroendocrine Cancer UK Ambassador, Simon

Neuroendocrine Cancer UK Ambassador, Simon

Please join us in welcoming our newest Ambassador, Simon to the team 🦋   Simon is 38, husband to Amy and father to three girls. Previously a Senior Vice Principal in secondary education. Here's Simon's story:   💬 I was diagnosed in October 2018 (aged 35) with two...

read more
Quality of Life Survey

Quality of Life Survey

Public Health England (PHE), NHS England and NHS Improvement (NHSE&I) have launched a nationwide Cancer Quality of Life Survey to find out how quality of life may have changed for people diagnosed with cancer. The information collected from the survey will help us...

read more